# Concordance Between Central Blood PRessure dEvices In Nephrology Patients

Study · id `cardio:ct-nct05963880` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05963880](<https://clinicaltrials.gov/study/NCT05963880>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05963880

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 119 participants.

## Technical summary

Registry record NCT05963880. Non-randomized; no masking; primary purpose diagnostic. Start 2021-04-26 (actual); primary completion 2024-11-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 119 participants (enrolled count; ClinicalTrials.gov record NCT05963880, source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)
- Started: 2021-04-26 (actual) (ClinicalTrials.gov record NCT05963880, source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)
- Primary completion: 2024-11-12 (actual) (ClinicalTrials.gov record NCT05963880, source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)
- Completion: 2024-11-12 (actual) (ClinicalTrials.gov record NCT05963880, source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05963880, source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05963880-2025-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Concordance Between Central Blood PRessure dEvices In Nephrology Patients
- Acronym: CBP-REIN
- Condition: Hypertension
- Condition: Chronic Kidney Disease
- Condition: Blood Pressure
- Intervention (Device): Brachial and Central BP measurements with Mobil-o-Graph NG device (IEM), WatchBP Office device (Microlife), BP+ device (Uscom) and Oscar 2 with SphygmoCor inside device (SunTech)
- Lead sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (`cardio:org-centre-integre-universitaire-de-sante-et-services-sociaux-f20430`)

## Provenance

Content hash: 8d0d7c5f68cd9601e154f225d203b669b51801c38bea68fc256de8c5f56722e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
